1. |
Buxbaum JN, Reixach NL. Transthyretin: the servant of many masters[J]. Cell Mol Life Sci, 2009, 66(19): 3095-3101. DOI: 10.1007/s00018-009-0109-0.
|
2. |
Hamilton JA, Benson MD. Transthyretin: a review from a structural perspective[J]. Cell Mol Life Sci, 2001, 58(10): 1491-1521. DOI: 10.1007/PL00000791.
|
3. |
Oshima Y, Deering T, Oshima S, et al. Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor[J]. J Cell Physiol, 2004, 199(3): 412-417. DOI: 10.1002/jcp.10442.
|
4. |
庄淼, 邵珺, 谭澄烨, 等. 转甲状腺素蛋白对视网膜微血管内皮细胞生物学行为的影响[J]. 中华眼底病杂志, 2015, 31(4): 368-370. DOI: 10.3760/cma.j.issn.1005-1015.2015.04.014.Zhuang M, Shao J, Tan CY, et al. Effects of transthyretin on biological behavior of retinal microvascular epithelial cell[J]. Chin J Ocul Fundus Dis, 2015, 31(4): 368-370. DOI: 10.3760/cma.j.issn.1005-1015.2015.04.014.
|
5. |
邵珺, 姚勇. 高糖缺氧环境下转甲状腺素蛋白对视网膜血管内皮细胞的影响[J]. 中华眼底病杂志, 2016, 32(2): 159-162. DOI: 10.3760/cma.j.issn.1005-1015.2016.02.011.Shao J, Yao Y. Transthyretinin repress retinal microvascular endothelial cells under high glucose and hypoxia environment[J]. Chin J Ocul Fundus Dis, 2016, 32(2): 159-162. DOI: 10.3760/cma.j.issn.1005-1015.2016.02.011.
|
6. |
Shao J, Yao Y. Transthyretin represses neovascularization in diabetic retinopathy[J]. Mol Vis, 2016, 22: 1188-1197.
|
7. |
Li X, Zarbin M, Bhagat N, et al. Anti-vascular endothelial growth factor injections: the new standard of care in proliferative diabetic retinopathy[J]. Dev Ophthalmol, 2017, 60: 131-142. DOI: 10.1159/000459699.
|
8. |
Chen X, Chen Q, Wang L, et al. Ghrelin induces cell migration through GHSR1a-mediated PI3K/Akt/eNOS/NO signaling pathway in endothelial progenitor cells[J]. Metabolism, 2013, 62(5): 743-752. DOI: 10.1016/j.metabol.2012.09.014.
|
9. |
Li J, Xuan W, Yan R, et al. Remote preconditioning provides potent eardioproteetion via PBK/Akt activation and is associated with nuclear accumulation of 3-catenin[J]. Clin Sci(Lond), 2011, 120(10): 451-462. DOI: 10.1042/CS20100466.
|
10. |
Kim HS, Kim SY, Kwak YL, et al. Hyperglycemia attenuates myocardial preconditioning of remifentanil[J]. J Surg Res, 2012, 174(2): 231-237. DOI: 10.1016/j.jss.2011.01.018.
|
11. |
Uehiyama T, Engelman RM, Maulik N, et al. Role of Akt signaling inmitoehondrial survival pathway triggered by hypoxic preconditioning[J]. Circulation, 2004, 109(24): 3042-3049. DOI: 10.1161/01.CIR.0000130647.29030.90.
|
12. |
Kaneda K, Miyamae M, Sugioka S, et al. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial K-ATP channels, and nitric oxide synthase, in guinea pig hearts[J]. Anesth Analg, 2008, 106(1): 9-16. DOI: 10.1213/01.ane.0000297298.93627.36.
|
13. |
Wallgren M, Lidman M, Pedersen A, et al. Reconstitution of the anti-apoptosis Bcl-2 protein into lipid membranes and biophysical evidence for its detergent-driven association with the pro-apoptotic Bax protein[J/OL]. PLoS One, 2013, 8(4): 61452[2013-04-23]. http://dx.plos.org/10.1371/journal.pone.0061452. DOI: 10.1371/journal.pone.0061452.
|
14. |
Siddiqui WA, Ahad A, Ahsan H. The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update[J]. Arch Toxicol, 2015, 89(3): 289-317. DOI: 10.1007/s00204-014-1448-7.
|